Author details

Full Name

William H Matthai

Affiliation

ORCID

Career Start Year

1986

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37356273	Pulmonary Embolism in Nonagenarians, a PERTinent Problem.		2023
36448401	Mechanical thrombectomy versus catheter directed thrombolysis in patients with pulmonary embolism: A multicenter experience.	Catheterization and Cardiovascular Interventions	2023
34881641	Interventional cardiologists' attitudes towards pharmacogenetic testing and impact on antiplatelet prescribing decisions.	Per Med	2022
34355815	Magnetic susceptibility and R2* of myocardial reperfusion injury at 3T and 7T.	Magn Reson Med	2022
34984913	Attitudes towardÂ pharmacogenetics in patients undergoing <i>CYP2C19</i> testing following percutaneous coronary intervention.	Per Med	2022
34783677	Intermediate-Term Outcomes for Patients with Submassive Pulmonary Embolism Treated With Catheter-Directed Thrombolysis.	Journal of Invasive Cardiology	2021
31498965	Invasive hemodynamic assessment of patients with submassive pulmonary embolism.	Catheterization and Cardiovascular Interventions	2020
31928229	Prospective <i>CYP2C19</i> Genotyping to Guide Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Pragmatic Randomized Clinical Trial.	Circ Genom Precis Med	2020
32030068	One-Year Outcomes of Percutaneous Coronary Intervention in Patients with End-Stage Liver Disease.	Clinical Medicine Insights: Cardiology	2020
32601301	Iron imaging in myocardial infarction reperfusion injury.	Nat Commun	2020
27976460	Interventional therapies and in-hospital outcomes in acute coronary syndromes complicated by von Willebrand disease.	Haemophilia	2017
28763308	Revascularization strategies and in-hospital management in acute coronary syndromes complicated by hemophilia A or hemophilia B.	Blood Coagulation and Fibrinolysis	2017
27443431	Hybrid Coronary Revascularization forÂ theÂ Treatment of Multivessel CoronaryÂ Artery Disease: A Multicenter Observational Study.	J Am Coll Cardiol	2016
25732742	Novel anti-platelet agents in acute coronary syndrome: mechanisms of action and opportunities to tailor therapy.	Curr Atheroscler Rep	2015
24477578	Atherosclerosis is not a risk factor for anti-platelet factor 4/heparin antibody formation after cardiopulmonary bypass surgery.	Thrombosis and Haemostasis	2014
21411997	Effective management of acute coronary thrombosis in a young woman with lupus using aggressive medical therapy.	Cardiology	2011
20418889	Meta-analysis and imputation refines the association of 15q25 with smoking quantity.	Nat Genet	2010
20703115	Evaluation of thrombocytopenia in the acute coronary syndrome.	Current Opinion in Hematology	2010
20933357	Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies.	J Am Coll Cardiol	2010
19198609	Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants.	Nat Genet	2009
19726820	Patient satisfaction is comparable to early discharge versus overnight observation after elective percutaneous coronary intervention.	J Invasive Cardiol	2009
18561143	Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts.	Catheterization and Cardiovascular Interventions	2008
17389785	Electron-beam computerized tomography correlates with coronary angiogram in chronic kidney disease patients.	American Journal of Nephrology	2007
17585381	Revascularization in severe left ventricular dysfunction: outcome comparison of drug-eluting stent implantation versus coronary artery by-pass grafting.	Catheterization and Cardiovascular Interventions	2007
16537053	Safety and efficacy of argatroban in patients with heparin-induced thrombocytopenia.	Current hematology reports	2006
16448321	Treatment of heparin-induced thrombocytopenia in cardiovascular patients.	Expert Opinion on Pharmacotherapy	2006
16892436	Improved survival with drug-eluting stent implantation in comparison with bare metal stent in patients with severe left ventricular dysfunction.	Catheterization and Cardiovascular Interventions	2006
15907526	Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.	Thrombosis Research	2005
15706030	Thrombocytopenia in cardiovascular patients: diagnosis and management.	Chest	2005
15744551	Argatroban anticoagulation in conjunction with glycoprotein IIb/IIIa inhibition in patients undergoing percutaneous coronary intervention: an open-label, nonrandomized pilot study.	Journal of Thrombosis and Thrombolysis	2004
15550014	Towards a diagnosis of heparin-induced thrombocytopenia after cardiopulmonary bypass.	Journal of Thrombosis and Haemostasis	2004
12927190	One-year clinical outcomes of protected and unprotected left main coronary artery stenting.	Eur Heart J	2003
12871688	Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention.	European Heart Journal	2003
12357516	Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.	Catheterization and Cardiovascular Interventions	2002
11948898	Evaluating the etiology of mechanical valve obstruction: use of clinical parameters, fluoroscopy, and echocardiography.	Catheterization and Cardiovascular Interventions	2002
11287711	Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention.	Journal of Invasive Cardiology	2001
11294800	Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.	Circulation	2001
11096663	Combination Enoxaparin and Abciximab During Percutaneous Coronary Intervention: A New Standard of Care?		2000
10801758	Randomized trial of contrast media utilization in high-risk PTCA: the COURT trial.	Circulation	2000
10731289	Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first".	Journal of Invasive Cardiology	2000
10731286	Catheter-induced spasm of the left main coronary artery.	Journal of Invasive Cardiology	2000
10856387	Predictors of clinical outcome following percutaneous intervention for in-stent restenosis.	Am J Cardiol	2000
10193724	Antithrombin activity during the period of percutaneous coronary revascularization: relation to heparin use, thrombotic complications and restenosis.	Journal of the American College of Cardiology	1999
10357153	Use of argatroban during percutaneous coronary interventions in patients with heparin-induced thrombocytopenia.	Seminars in Thrombosis and Hemostasis	1999
9408613	Complications of cardiac angiography using low- or high-osmolality contrast agents in patients with left main coronary stenosis.		1997
9205023	Expected hemoglobin decrease following percutaneous transluminal coronary angioplasty.	American Journal of Cardiology	1997
8922326	Internal mammary arteriography without selective cannulation using a new balloon occlusion catheter.		1996
8557507	Adverse effects of calcium binding contrast agents in diagnostic cardiac angiography. A comparison between formulations with and without calcium binding additives.	Investigative Radiology	1995
7489597	Initial experience with an intracoronary flow support device providing localized drug infusion: the Scimed Dispatch catheter.		1995
8281660	A comparison of low- with high-osmolality contrast agents in cardiac angiography. Identification of criteria for selective use.	Circulation	1994